In last trading session, Emergent Biosolutions Inc (NYSE:EBS) saw 1.02 million shares changing hands with its beta currently measuring 1.98. Company’s recent per share price level of $6.99 trading at $0.06 or 0.87% at ring of the bell on the day assigns it a market valuation of $379.41M. That closing price of EBS’s stock is at a discount of -116.02% from its 52-week high price of $15.10 and is indicating a premium of 42.49% from its 52-week low price of $4.02. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.13 million shares which gives us an average trading volume of 1.28 million if we extend that period to 3-months.
For Emergent Biosolutions Inc (EBS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Emergent Biosolutions Inc (NYSE:EBS) trade information
Upright in the green during last session for gaining 0.87%, in the last five days EBS remained trading in the red while hitting it’s week-highest on Monday, 07/14/25 when the stock touched $6.99 price level, adding 8.63% to its value on the day. Emergent Biosolutions Inc’s shares saw a change of -34.37% in year-to-date performance and have moved -4.64% in past 5-day. Emergent Biosolutions Inc (NYSE:EBS) showed a performance of 11.84% in past 30-days. Number of shares sold short was 7.99 million shares which calculate 7.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 51.5 to the stock, which implies a rise of 86.43% to its current value. Analysts have been projecting 38 as a low price target for the stock while placing it at a high target of 65. It follows that stock’s current price would drop -443.63% in reaching the projected high whereas dropping to the targeted low would mean a loss of -443.63% for stock’s current value.
Emergent Biosolutions Inc (NYSE:EBS)’s Major holders
Insiders are in possession of 2.83% of company’s total shares while institution are holding 67.20 percent of that, with stock having share float percentage of 69.16%. Investors also watch the number of corporate investors in a company very closely, which is 67.20% institutions for Emergent Biosolutions Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at EBS for having 3.84 million shares of worth $26.18 million. And as of 2024-06-30, it was holding 7.2992 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 3.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.97 of outstanding shares, having a total worth of $25.0 million.
On the other hand, American Century ETF Trust-Avantis U.S. Small Cap Value ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 1.94 shares of worth $13.59 million or 3.58% of the total outstanding shares. The later fund manager was in possession of 1.57 shares on Mar 31, 2025 , making its stake of worth around $10.99 million in the company or a holder of 2.90% of company’s stock.
